Results 101 to 110 of about 11,661 (217)

Mycobacterium abscessus Displays Fitness for Fomite Transmission

open access: yes, 2017
Mycobacterium abscessus is a rapidly growing nontuberculous mycobacterium (NTM) increasingly reported in soft tissue infections and chronic lung diseases, including cystic fibrosis. The environmental source of M. abscessus
Silvia M. Caceres   +7 more
core   +1 more source

Peritoneal dialysis-associated infection caused by Mycobacterium abscessus: a case report

open access: yesBMC Nephrology, 2018
Background Peritoneal dialysis (PD)-associated infection caused by Mycobacterium spp. is rare. Mycobacterium abscessus is one of the most resistant acid-fast bacteria, and treatment is also the most difficult and refractory.
Ryuichi Yoshimura   +8 more
doaj   +1 more source

Biofilm Associated Persistence and Drug Tolerance in Mycobacteria Within Host Microenvironments

open access: yesAPMIS, Volume 134, Issue 3, March 2026.
ABSTRACT Biofilms formed by mycobacteria, particularly Mycobacterium tuberculosis (Mtb), represent a major challenge in tuberculosis (TB) treatment due to their highly organized structure and their capacity to induce phenotypic drug tolerance. These three‐dimensional bacterial aggregates are embedded in a self‐produced extracellular matrix that ...
Lourdes Serrano Garcia   +3 more
wiley   +1 more source

Lung organoids as a human system for Mycobacteria infection modeling and drug testing

open access: yesThe FEBS Journal, Volume 293, Issue 6, Page 1587-1611, March 2026.
Mycobacterial infections, including tuberculosis (TB) and infections by nontuberculous mycobacteria (NTM), are still public health issues. In 2023, TB caused 1.25 million deaths, while NTM remain a clinical challenge for patients with cystic fibrosis (CF).
Stephen Adonai Leon‐Icaza   +4 more
wiley   +1 more source

Cytotoxicity and Antimicrobial Activity of GaMF1 Analogs

open access: yesChemMedChem, Volume 21, Issue 4, 25 February 2026.
GaMF1 is a reported, highly potent inhibitor of mycobacterial ATP synthase. Structural modification of this scaffold significantly changes biological activity. We present GaMF1 analogues with strong antiparasitic effects, potential antiproliferative properties, and discuss the selectivity limitations of the parent compound and its analogues.
Jan Chasák   +8 more
wiley   +1 more source

Phenogenomics of Mycobacterium abscessus

open access: yesNature Microbiology, 2022
Iñaki Comas, Miguel Moreno-Molina
openaire   +2 more sources

Treating Primary Arthroprosthesis Infection Caused by Mycobacterium abscessus subsp. abscessus

open access: yes, 2019
Prosthetic joint infections (PJI) caused by nontuberculous mycobacteria are very rare, and results of treatment can be unpredictable. A 72-year-old female underwent hip replacement after an accidental fall in a local hospital in Santo Domingo.
Claudio Piersimoni   +11 more
core   +1 more source

Successful management of Mycobacterium abscessus complex lung disease in an otherwise healthy infant

open access: yes, 2019
Hui Liu,1 Fang Dong,2 Jinrong Liu,1 Jianhua Liu,3 Yu Pang,4 Shunying Zhao,1 Jie Lu,5 Huimin Li11Department of Respiratory Medicine, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing ...
Liu H   +6 more
core  

Mycobacterium abscessus infection in a spa worker

open access: yesActa Dermatovenerologica Alpina Pannonica et Adriatica, 2018
Mycobacterium abscessus (M. abscessus) is a non-tuberculous mycobacterium widely present in the natural environment and is now being increasingly identified as a cause of human disease. However, it can cause skin and soft tissue infection following trauma or surgery. We report a case of a skin ulcer associated with M.
Miguel, Costa-Silva   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy